Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 3/20 | 0.35 |
| ▸ | CHRM5 known ✓ | P08912 | 3/20 | 0.34 |
| ▸ | CHRM1 known ✓ | P11229 | 3/20 | 0.34 |
| ▸ | CHRM3 known ✓ | P20309 | 3/20 | 0.34 |
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 known ✓ | P08173 | 2/20 | 0.34 |
| ▸ | GALR3 | O60755 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.34 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2694530 | 0.98 | ACHE (0.37) | GALR3GAARAB9AACHECHRM5 | |
| Iodide SCHEMBL17105890 | 0.96 | ACHE (0.35) | GALR3GAARAB9AACHECHRM5 | |
| SCHEMBL31354833 | 0.96 | ACHE (0.35) | GALR3GAARAB9AACHECHRM5 | |
| Fluoride Ion SCHEMBL17105876 | 0.96 | ACHE (0.35) | GALR3GAARAB9AACHECHRM5 | |
| Iodide SCHEMBL7927481 | 0.96 | ACHE (0.35) | GALR3GAARAB9AACHECHRM5 | |
| Hydrochloric Acid SCHEMBL422218 | 0.96 | CHRM5 (0.38) | GALR3GAARAB9AACHECHRM5 | |
| Phosphoric Acid SCHEMBL28400122 | 0.90 | BBOX1 (0.35) | GALR3GAARAB9AACHECHRM5 | |
| Sulfuric Acid SCHEMBL6478255 | 0.89 | BBOX1 (0.34) | GALR3ACHECHRM5CHRM1CHRM3 | |
| Bromide SCHEMBL718176 | 0.88 | ACHE (0.42) | GALR3GAARAB9AACHECHRM5 | |
| Phosphoric Acid SCHEMBL17105879 | 0.87 | ACHE (0.34) | GALR3ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250360491-A1 | STATIONARY PHASE FOR CHROMATOGRAPHY | DAICEL CORPORATION (JP) | 2025-11-27 | — | — | US | disclosed |
| US-12403452-B2 | Stationary phase for chromatography | DAICEL CORPORATION (JP) | 2025-09-02 | — | — | US | disclosed |
| CN-119425650-A | Stationary phase for chromatography | 株式会社大赛璐 | 2025-02-14 | — | — | CN | disclosed |
| WO-2025034831-A1 | SURFACTANTS FOR CLEANING PRODUCTS | ADVANSIX RESINS & CHEMICALS LLC (US) | 2025-02-13 | — | — | WO | disclosed |
| US-20250051686-A1 | SURFACTANTS FOR CLEANING PRODUCTS | ADVANSIX RESINS & CHEMICALS LLC (US) | 2025-02-13 | — | — | US | disclosed |
| US-20240376412-A1 | SURFACTANTS FOR CLEANING PRODUCTS | ADVANSIX RESINS & CHEMICALS LLC (US) | 2024-11-14 | — | — | US | disclosed |
| US-12134748-B2 | Branched amino acid surfactants for cleaning products | ADVANSIX RESINS & CHEMICALS LLC (US) | 2024-11-05 | — | — | US | disclosed |
| US-12071600-B2 | Surfactants for cleaning products | ADVANSIX RESINS & CHEMICALS LLC (US) | 2024-08-27 | — | — | US | disclosed |
| CN-112638519-B | stationary phase for chromatography | 株式会社大赛璐 | 2023-11-10 | — | — | CN | disclosed |
| EP-4179051-A1 | BRANCHED AMINO ACID SURFACTANTS FOR CLEANING PRODUCTS | AdvanSix Resins & Chemicals LLC (US) | 2023-05-17 | — | — | EP | disclosed |
| CN-106459842-A | Cleaning compositions comprising cationic polymers and methods of making and using the same | 宝洁公司 | 2017-02-22 | — | — | CN | disclosed |
| US-20160237381-A1 | CLEANING COMPOSITIONS CONTAINING ALKYL SULFATE SURFACTANTS AND CATIONIC POLYMER FOR HOLISTIC IMPROVEMENT OF SUDSING PROFILE | THE PROCTER & GAMBLE COMPANY | 2016-08-18 | — | — | US | disclosed |
| US-20160130528-A1 | DETERGENT OR CLEANING COMPOSITIONS WITH IMPROVED SUDSING PROFILE | THE PROCTER & GAMBLE COMPANY | 2016-05-12 | — | — | US | disclosed |
| US-20150376552-A1 | CLEANING COMPOSITIONS CONTAINING CATIONIC POLYMERS, AND METHODS OF MAKING AND USING SAME | THE PROCTER & GAMBLE COMPANY | 2015-12-31 | — | — | US | disclosed |
| US-9150414-B2 | Nanocomposite and dispersion comprising the same | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20150275135-A1 | CLEANING COMPOSITION CONTAINING CATIONIC POLYMERS AND METHODS OF MAKING AND USING SAME | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | disclosed |
| WO-2015143645-A1 | CLEANING COMPOSITIONS CONTAINING CATIONIC POLYMERS, AND METHODS OF MAKING AND USING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2015-10-01 | — | — | WO | disclosed |
| US-9093196-B2 | Conductive particles and method of preparing the same | NISSHINBO HOLDINGS, INC. (JP) | 2015-07-28 | — | — | US | disclosed |
| US-20120053288-A1 | NANOCOMPOSITE AND DISPERSION COMPRISING THE SAME | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2012-03-01 | — | — | US | disclosed |
| US-20080078977-A1 | CONDUCTIVE PARTICLES AND METHOD OF PREPARING THE SAME | NISSHINBO INDUSTRIES, INC. (JP) | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051686-A1 | SURFACTANTS FOR CLEANING PRODUCTS | DAGLA, DSG1, DEGS1 | ACHE 125/4885CHRM5 370/4885CHRM1 592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.